AFJK
Aimei Health·NASDAQ
--
--(--)
--
--(--)
AFJK fundamentals
During Q3 2025, Aimei Health (AFJK) reported revenue of --, a YoY change of 0.00%. Net income was 352.02K, a YoY change of -52.65%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | TTM |
|---|
Start Date | Apr 27, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | -- |
End Date | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Operating Expenses | 3.62K -- | 0 -- | 24.84K -- | 153.63K -- | 309.11K +8443.78% | 200.02K -- | 402.02K +1518.38% | 413.41K +169.09% | 41.60K -86.54% | 130.15K -34.93% | 987.19K -- |
Selling, General and Administrative Expenses | -- -- | 0 -- | -3.62K -- | 153.63K -- | 309.11K -- | 200.02K -- | -662.76K -18218.55% | 413.41K +169.09% | 41.60K -86.54% | 130.15K -34.93% | -77.59K -- |
Other Operating Expenses | 3.62K -- | -- -- | 28.46K -- | -- -- | -- -- | -- -- | 1.06M +3641.47% | -- -- | -- -- | -- -- | -- -- |
Operating Income | -3.62K -- | 0 -- | -24.84K -- | -153.63K -- | -309.11K -8443.78% | -200.02K -- | -402.02K -1518.38% | -413.41K -169.09% | -41.60K +86.54% | -130.15K +34.93% | -987.19K -- |
Non-Operating Income (Loss) | -- -- | 0 -- | 199.85K -- | 909.13K -- | 918.21K -- | 943.53K -- | 846.13K +323.39% | 598.08K -34.21% | 466.57K -49.19% | 482.17K -48.90% | 2.39M -- |
Net Interest Expense | -- -- | 0 -- | -199.85K -- | -909.13K -- | -918.21K -- | -943.53K -- | -846.13K -323.39% | -598.08K +34.21% | -466.57K +49.19% | -482.17K +48.90% | -2.39M -- |
Interest Income | -- -- | 0 -- | 199.85K -- | 909.13K -- | 918.21K -- | 943.53K -- | 846.13K +323.39% | 598.08K -34.21% | 466.57K -49.19% | 482.17K -48.90% | 2.39M -- |
Pretax Income From Continuing Operations | -3.62K -- | -- -- | 175.01K -- | 755.50K -- | 609.09K +16935.05% | 743.51K -- | 444.11K +153.77% | 184.66K -75.56% | 424.97K -30.23% | 352.02K -52.65% | 1.41M -- |
Net Income | -3.62K -- | -- -- | 175.01K -- | 755.50K -- | 609.09K +16935.05% | 743.51K -- | 444.11K +153.77% | 184.66K -75.56% | 424.97K -30.23% | 352.02K -52.65% | 1.41M -- |
Net Income Attributable to Owners of the Company | -3.62K -- | 0 -- | 175.01K -- | 755.50K -- | 609.09K +16935.05% | 743.51K -- | 444.11K +153.77% | 184.66K -75.56% | 424.97K -30.23% | 352.02K -52.65% | 1.41M -- |
Net Income Attributable to Common Stockholders | -3.62K -- | 0 -- | 175.01K -- | 755.50K -- | 609.09K +16935.05% | 743.51K -- | 444.11K +153.77% | 184.66K -75.56% | 424.97K -30.23% | 352.02K -52.65% | 1.41M -- |
Total Comprehensive Income Attributable to Owners of the Company | -- -- | -- -- | 171.39K -- | -- -- | -- -- | -- -- | 2.55M +1389.14% | -- -- | -- -- | -- -- | -- -- |
Basic EPS | 0 -- | 0 -- | -- -- | 0.08 -- | 0.07 -- | 0.16 -- | 0.05 -- | 0.03 -62.50% | 0.07 -- | 0.12 -25.00% | 0.27 -- |
Basic EPS from Continuing Operations | -- -- | 0 -- | -- -- | 0.08 -- | 0.07 -- | 0.16 -- | -- -- | 0.03 -62.50% | 0.07 -- | 0.12 -25.00% | -- -- |
Diluted EPS | 0 -- | 0 -- | -- -- | 0.08 -- | 0.07 -- | 0.16 -- | -- -- | 0.03 -62.50% | 0.07 -- | 0.12 -25.00% | -- -- |
Diluted EPS from Continuing Operations | -- -- | 0 -- | -- -- | 0.08 -- | 0.07 -- | 0.16 -- | -- -- | 0.03 -62.50% | 0.07 -- | 0.12 -25.00% | -- -- |
You can ask Aime
What is the market's earnings forecast for Aimei Health next quarter?What is the revenue and EPS growth rate for Aimei Health year over year?What does Aimei Health do and what are its main business segments?Did Aimei Health beat or miss consensus estimates last quarter?What is Aimei Health's latest dividend and current dividend yield?What is Aimei Health's gross profit margin?What were the key takeaways from Aimei Health's earnings call?What were the key takeaways from Aimei Health’s earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
